Patient education and support are important components of treatment of patients with depression. However, Hispanic patients may face language barriers in communicating with non-Spanish-speaking caregivers and understanding English-only patient support tools.
Responding to the needs of the fastest growing and largest minority group in the United States, Wyeth Pharmaceuticals has launched a unique Spanish-language patient education and support program titled Dialogues: Time to Talk®. The program offers educational resources and support to open communication channels, increase awareness and enhance treatment outcomes.
Patients with depression who are taking EFFEXOR XR® (venlafaxine HCl) who enroll in the Spanish Dialogues: Time to Talk program will receive educational materials that have been developed in consultation with physicians and patients to help address common therapeutic needs of patients taking EFFEXOR XR for depression.
Patients are provided additional support to aid in their treatment through both a Spanish Dialogues: Time to Talk Web site, www.HoraDeHablar.com, and optional telephone-support services, which include three calls from bilingual nurses and unlimited calls to a helpline. Patients are asked a series of questions by phone and can enter responses via the touch pad. Within 48 hours, the responses are sent to the patient's physician regarding the patient's mood, sleep levels, energy, appetite, concentration, social functioning, self-harm and medication adherence.
"This program is particularly important for Hispanic patients who may have difficulty communicating with non-Spanish-speaking physicians and may be vulnerable to early discontinuation of treatment, which may lead to future episodes of depression," says Pedro Delgado, M.D., Chair of the Department of Psychiatry, University of Texas Health Science Center at San Antonio. "The Dialogues: Time to Talk program seeks to help open communication channels for this community while providing educational resources."
For more information, visit www.HoraDeHablar.com.